2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

10- Intestinal Transplantation

52.3 - Donor Risk Index for Intestinal & Multi-visceral Transplantation

Presenter: Hiroshi, Sogawa, Valhalla, United States
Authors: Hiroshi Sogawa, Gang Zeng, Menghan Chen, Xiaomu Zhao, Ruy Cruz, Douglas Landsittel

Donor Risk Index for Intestinal & Multi-visceral Transplantation

Hiroshi Sogawa1,4, Gang Zeng2, Menghan Chen3, Xiaomu Zhao2, Ruy Cruz4, Douglas Landsittel3.

1Intra-abdominal & Hepatobiliary Surgery, New York Medical College/ Westchester Medical Center, Valhalla, NY, United States; 2Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, United States; 3Division of General Internal Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, PA, United States; 4Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, United States

Introduction: Intestinal and multi-visceral transplantation (IT & MVT) have been a standard procedure with a total of 2600 cases performed in the US and 3500 all over the world. Their recent outcome has improved over the last two decades. Donor selection is essential for successful IT & MVT. We tend to use a very selected group of donors such as young, hemodynamically stable donor for IT & MVT compared to donors for liver or kidney transplantation in current practice. Donor selection has been examined in liver and kidney transplantation. Donor Risk Index for liver (DRI) and kidney transplantation (KDPI) have been developed. However, there is not an index created for IT & MVT transplantation yet. This is the first study to comprehensively examine donor risk factors for IT & MVT with intention to make donor risk index formula in IT & MVT transplantation.

Methods: Retrospective data collection from UNOS database was used. Data from The United Network for Organ Sharing (UNOS) of 2,439 IT & MVT transplant patients between 1990 to 2014 were analyzed. IT & MVT transplant patients were categorized into three main types of visceral transplantation (I-intestine, II-liver-intestine, and III-multivisceral[III-1 full/ III-2 modified]). Cox regression was used to model the risk of death or graft loss, based on donor and transplant factors, adjusting for recipient factors. 

Results: Univariate and multivariate analysis were performed for patient and graft survival. Risk factors were chosen for donor risk index formula. Those were donor's race, weight, cause of death, total birilubin, GOT, recipient's birilubin, ICU status, albumin, type of transplant. We have developed IT & MVT donor risk index (IDRI) as figure 1. IDRI predict post transplantation graft survival (Kaplan-Meier) well as Figure 2.

Conclusions/ Discussions: IDRI predicts intestinal graft survival. IDRI can be used for risk-stratification when we select a donor for intestinal and multivisceral transplantation in an objective way. Possibly IDRI can be used for allocation algorithm for IT & MVT in the future.

UNOS/ OPTN.

[1] Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM,Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index.Am J Transplant 2006;6:783-790.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada